Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 868
117th Congress(2021-2022)
Huntington’s Disease Disability Insurance Access Act of 2021
Introduced
Introduced
Introduced in Senate on Mar 18, 2021
Overview
Text
Introduced in Senate 
Mar 18, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Mar 18, 2021)
Mar 18, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 868 (Introduced-in-Senate)


117th CONGRESS
1st Session
S. 868


To amend title II of the Social Security Act to eliminate the five-month waiting period for disability insurance benefits under such title and waive the 24-month waiting period for Medicare eligibility for individuals with Huntington’s disease.

IN THE SENATE OF THE UNITED STATES

March 18, 2021

Mrs. Gillibrand (for herself, Mr. Cassidy, and Mr. King) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To amend title II of the Social Security Act to eliminate the five-month waiting period for disability insurance benefits under such title and waive the 24-month waiting period for Medicare eligibility for individuals with Huntington’s disease.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Huntington’s Disease Disability Insurance Access Act of 2021”.

SEC. 2. Elimination of waiting period for social security disability insurance benefits for individuals with Huntington’s disease.

(a) In general.—Section 223(a)(1) of the Social Security Act (42 U.S.C. 423(a)(1)) is amended, in the matter following subparagraph (E), by inserting “or Huntington’s disease” after “amyotrophic lateral sclerosis”.

(b) Effective date.—The amendment made by subsection (a) shall apply with respect to applications for disability insurance benefits filed after the date of the enactment of this Act.

SEC. 3. Waiver of 24-month waiting period for coverage under the Medicare program for individuals with Huntington’s disease.

(a) In general.—Section 226(h) of the Social Security Act (42 U.S.C. 426(h)) is amended, in the matter preceding paragraph (1), by inserting “or Huntington’s disease (HD)” after “amyotrophic lateral sclerosis (ALS)”.

(b) Effective date.—The amendment made by subsection (a) shall apply to benefits under title XVIII of the Social Security Act with respect to items and services furnished in months beginning after the date of the enactment of this Act.